ONCORUS, INC.

EDGAR

16 filing records in this dataset, filed from 2020-09-11 to 2023-05-22. Reported financial figures are available; chart coverage varies by period.

Watchlist
Cash and cash equivalents
21.2 million USD Source
Exact value

21217000 USD

Long-term debt including current maturities
20 million USD Source
Exact value

20000000 USD

Shares outstanding
26.1 million shares Source
Exact value

26095000 shares

Reported share-count change

0.82% · 212 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 25883000 shares · 2022-03-31· Source
  • 26095000 shares · 2023-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-90.5 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence
  • Net income: -19091000 USD · 2022-04-01 – 2022-06-30 Source
  • Net income: -19620000 USD · 2022-07-01 – 2022-09-30 Source
  • Net income: -77400000 USD · 2022-01-01 – 2022-12-31 Source
  • Net income: -56491000 USD · 2022-01-01 – 2022-09-30 Source
  • Net income: -30900000 USD · 2023-01-01 – 2023-03-31 Source

Operating cash flow

-55.7 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence
  • Operating cash flow: -36694000 USD · 2022-01-01 – 2022-06-30 Source
  • Operating cash flow: -23437000 USD · 2022-01-01 – 2022-03-31 Source
  • Operating cash flow: -47548000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -36694000 USD · 2022-01-01 – 2022-06-30 Source
  • Operating cash flow: -61688000 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -47548000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -17447000 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

18.1 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence
  • Capital expenditure: 6561000 USD · 2022-01-01 – 2022-06-30 Source
  • Capital expenditure: 1868000 USD · 2022-01-01 – 2022-03-31 Source
  • Capital expenditure: 14483000 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 6561000 USD · 2022-01-01 – 2022-06-30 Source
  • Capital expenditure: 19933000 USD · 2022-01-01 – 2022-12-31 Source
  • Capital expenditure: 14483000 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 73000 USD · 2023-01-01 – 2023-03-31 Source

Free cash flow

-73.8 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence
  • Operating cash flow: -36694000 USD · 2022-01-01 – 2022-06-30 Source
  • Operating cash flow: -23437000 USD · 2022-01-01 – 2022-03-31 Source
  • Operating cash flow: -47548000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -36694000 USD · 2022-01-01 – 2022-06-30 Source
  • Operating cash flow: -61688000 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -47548000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -17447000 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 6561000 USD · 2022-01-01 – 2022-06-30 Source
  • Capital expenditure: 1868000 USD · 2022-01-01 – 2022-03-31 Source
  • Capital expenditure: 14483000 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 6561000 USD · 2022-01-01 – 2022-06-30 Source
  • Capital expenditure: 19933000 USD · 2022-01-01 – 2022-12-31 Source
  • Capital expenditure: 14483000 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 73000 USD · 2023-01-01 – 2023-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-05-22.

Financial data available through: 2022-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 5 of 11 periods available· newest 2022-12-31
  • Net income: 5 of 11 periods available· newest 2022-12-31
  • Operating cash flow: 5 of 11 periods available· newest 2022-12-31
  • Capital expenditure: 5 of 11 periods available· newest 2022-12-31
  • Total assets: 5 of 11 periods available· newest 2022-12-31
  • Total liabilities: 5 of 11 periods available· newest 2022-12-31
  • Current assets: 5 of 11 periods available· newest 2022-12-31
  • Current liabilities: 5 of 11 periods available· newest 2022-12-31
  • Cash and cash equivalents: 5 of 11 periods available· newest 2022-12-31
  • Long-term debt including current maturities: 2 of 11 periods available· newest 2022-12-31
  • Shares outstanding: 5 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 12.64 million

    Prior period

    −USD 64.76 million

    –

    Current period

    −USD 77.4 million

    –

    Exact inputs and evidence

    -77400000 − -64762000 = -12638000 USD

    -64762000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -77400000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 11.86 million

    Prior period

    −USD 49.82 million

    –

    Current period

    −USD 61.69 million

    –

    Exact inputs and evidence

    -61688000 − -49824000 = -11864000 USD

    -49824000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -61688000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +108.7%

    Prior period

    USD 9.55 million

    –

    Current period

    USD 19.93 million

    –

    Exact inputs and evidence

    19933000 − 9549000 = 10384000 USD

    9549000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    19933000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2018 2018-01-01 – 2018-12-31
−USD 18.05 million
Exact value

Exact value: -18046000 USD

2018-01-01 – 2018-12-31: -18046000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 17.16 million
Exact value

Exact value: -17163000 USD

2018-01-01 – 2018-12-31: -17163000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 291,000
Exact value

Exact value: 291000 USD

2018-01-01 – 2018-12-31: 291000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 17.45 million
Calculation and evidence

-17163000 − 291000 USD

Exact free cash flow: -17454000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 30.7 million
Exact value

Exact value: -30704000 USD

2019-01-01 – 2019-12-31: -30704000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 27.2 million
Exact value

Exact value: -27204000 USD

2019-01-01 – 2019-12-31: -27204000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 977,000
Exact value

Exact value: 977000 USD

2019-01-01 – 2019-12-31: 977000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 28.18 million
Calculation and evidence

-27204000 − 977000 USD

Exact free cash flow: -28181000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 48.3 million
Exact value

Exact value: -48299000 USD

2020-01-01 – 2020-12-31: -48299000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 36.81 million
Exact value

Exact value: -36807000 USD

2020-01-01 – 2020-12-31: -36807000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.06 million
Exact value

Exact value: 1056000 USD

2020-01-01 – 2020-12-31: 1056000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 37.86 million
Calculation and evidence

-36807000 − 1056000 USD

Exact free cash flow: -37863000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 64.76 million
Exact value

Exact value: -64762000 USD

2021-01-01 – 2021-12-31: -64762000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 49.82 million
Exact value

Exact value: -49824000 USD

2021-01-01 – 2021-12-31: -49824000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 9.55 million
Exact value

Exact value: 9549000 USD

2021-01-01 – 2021-12-31: 9549000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 59.37 million
Calculation and evidence

-49824000 − 9549000 USD

Exact free cash flow: -59373000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 77.4 million
Exact value

Exact value: -77400000 USD

2022-01-01 – 2022-12-31: -77400000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 61.69 million
Exact value

Exact value: -61688000 USD

2022-01-01 – 2022-12-31: -61688000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 19.93 million
Exact value

Exact value: 19933000 USD

2022-01-01 – 2022-12-31: 19933000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 81.62 million
Calculation and evidence

-61688000 − 19933000 USD

Exact free cash flow: -81621000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

16 filings · 756 latest values · 756 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001671818, 1671818, ONCR, edgar:1671818

Also known as ONCORUS, INC., Oncorus, Inc.